Skip to main content
Equibles

Blackstone Inc.

Position in ALEC — Alector, Inc.

CIK 1393818 NEW YORK, NY
Back to ALEC Full portfolio

Position in ALEC

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$155,061
-$10,800 QoQ
Shares Held
77,145
0.0% QoQ
Ownership
0.069%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#62
of 140 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in ALEC Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Blackstone Inc. holds $252,665,757 across 52 Biotechnology names. ALEC ranks #51 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 AUTL
Autolus Therapeutics plc
 20,485,611 $32,776,977
2 DFTX
Definium Therapeutics, Inc.
 561,612 $26,418,228
3 DMRA
Damora Therapeutics, Inc.
 1,002,971 $26,087,275
4 ARTV
Artiva Biotherapeutics, Inc.
 2,403,437 $23,313,338
5 ORKA
Oruka Therapeutics, Inc.
 237,108 $22,565,568
6 ALXO
Alx Oncology Holdings Inc
 6,593,543 $13,648,634
7 XFOR
X4 Pharmaceuticals, Inc
 2,681,922 $12,524,575
8 IKT
Inhibikase Therapeutics, Inc.
 5,938,276 $12,054,700

All Filings in ALEC

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $155,061 77,145
2026-03-31 $165,861 77,145
2025-12-31 $104,300 66,859
2025-09-30 $76,116 25,715
2025-06-30 $36,001 25,715
2025-03-31 $31,629 25,715
2024-12-31 $48,601 25,715
2024-09-30 $119,831 25,715
2024-06-30 $116,746 25,715
2024-03-31 $92,882 15,429
2023-12-31 $123,123 15,429
2023-09-30 $99,979 15,429
2023-06-30 $61,818 10,286
2023-03-31 $63,670 10,286
2022-12-31 $94,939 10,286